Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Dalmau, A. Gleichman, Ethan Hughes, J. Rossi, Xiaoyu Peng, Meizan Lai, S. Dessain, M. Rosenfeld, R. Balice-Gordon, D. Lynch (2008)
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 7
A. Boronat, L. Sabater, A. Saiz, J. Dalmau, F. Graus (2011)
GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disordersNeurology, 76
E. Lancaster, E. Martínez-Hernandez, J. Dalmau (2011)
Encephalitis and antibodies to synaptic and neuronal cell surface proteinsNeurology, 77
M. Folstein, M. Folstein, S. Folstein, S. Folstein, P. McHugh, P. McHugh (1975)
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 12
(2011)
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology
R. Caselli, B. Boeve, B. Scheithauer, J. O'duffy, G. Hunder (1999)
Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy.Neurology, 53 7
E. Lancaster, Meizan Lai, Xiaoyu Peng, Ethan Hughes, R. Constantinescu, J. Raizer, D. Friedman, Mark Skeen, W. Grisold, A. Kimura, K. Ohta, T. Iizuka, Miguel Guzman, F. Graus, S. Moss, R. Balice-Gordon, J. Dalmau (2010)
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 9
OBSERVATION Treatment of -Aminobutyric Acid Receptor–Antibody Autoimmune Encephalitis With Oral Corticosteroids Daniel M. Goldenholz, MD, PhD; Victoria S. S. Wong, MD; Lisa M. Bateman, MD, FRCPC; Michelle Apperson, MD, PhD; Bjorn Oskarsson, MD; Shahrzad Akhtar, MD; Vicki Wheelock, MD Background: Autoimmune encephalitis is increas- Patient: A 43-year-old man with initial presentation of ingly identified as a cause of nonviral, idiopathic en- seizures and altered mental status. cephalitis. Present treatment algorithms recommend costly Intervention: Our patient was treated with an ex- immune-modulating treatments and do not identify a role tended course of oral corticosteroids as an outpatient. for oral corticosteroids. Results: After treatment with oral corticosteroids, our patient had steady clinical improvement, achieved sei- Objective: To present a patient with -aminobutyric zure freedom, and experienced improved mental status acid receptor–antibody encephalitis before and after treat- to within normal limits. ment with oral corticosteroids. Conclusions: This case supports the use of low-cost oral corticosteroids in treating patients with -aminobutyric Design: Case report. acid receptor–antibody encephalitis. Setting: The inpatient course as well as outpatient fol- Arch Neurol. 2012;69(8):1061-1063. Published online low-up is discussed. April 16, 2012. doi:10.1001/archneurol.2012.197 UTOIMMUNE ENCEPHALITI- full-body stiffness for 1 to 2 minutes. Ad- des involve an inflamma- ditional
JAMA Neurology – American Medical Association
Published: Aug 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.